The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | Updated BSH guidelines for non-clonal polycythemia
Mary Frances McMullin, MD, Queen’s University Belfast, Belfast, UK, discusses the updated polycythaemia vera (PV) and secondary erythrocytosis guidelines produced by British Society for Haematology (BSH). Prof. McMullin higlights the updates on idiopathic and congenital erythrocytosis. The previous guideline was published in 2005 (McMullin et al, 2005) with an amendment in 2007 (McMullin et al, 2007) to update the diagnostic criteria following the discovery of the JAK2 mutation in patients with PV. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
